AI companies are enabling genocide in China
By Michael Chertoff and N. MacDonnell Ulsch,
The Washington Post
| 04. 12. 2021
"Uyghur man" by Evgeni Zotov is
licensed under CC BY-NC-ND 2.0
The Chinese Communist Party’s persecution of the Uyghur people will go down in history as one of the worst human rights tragedies of our time — not just for the abject horror of targeting a population of 11 million for genocide, but also for the advanced technologies that enabled it.
Like most Chinese citizens, the Uyghurs have long been under constant high-tech surveillance that tracks, analyzes and records their every move and scours their personal communications for evidence of dissent. Compounding this culture of surveillance is the evolution of artificial intelligence from a novelty designed to win games of chess against humans into a science now capable of facial recognition and individual profiling. The Uyghurs have lived in China since the 9th century, yet their persecution has been driven by 21st-century technology.
Beijing has vowed to lead the world in AI, and its documented use in the identification and detention of Uyghurs shows that the regime is getting there quickly. The implications of this campaign are dire. A new...
Related Articles
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Ben Fidler and Ned Pagliarulo, Biopharma Dive | 07.21.2025
One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening.
The man died...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...